Streetbeat News

Regulatory

PFE

The FDA has voted in favor of Pfizer's maternal RSV vaccine candidate, RSVpreF, supporting its efficacy and safety. If approved, it could become the first maternal vaccine against the virus. Analysts estimate the market for RSV vaccines to surpass $10 billion by 2030.

Portfolio Pulse from Vandana Singh

May 19, 2023 | 1:02 pm

TMO

The FDA has approved Thermo Fisher Scientific's blood test for preeclampsia, a pregnancy-related illness. The test is the first blood-based biomarker immunoassay to receive breakthrough designation and clearance for risk assessment and clinical management of preeclampsia.

Portfolio Pulse from Vandana Singh

May 19, 2023 | 1:00 pm

GOOG

GOOGL

INDA

India's IT Ministry is planning action against Google following findings of anti-competitive practices, which are of deep concern for the country.

Portfolio Pulse from Happy Mohamed

May 19, 2023 | 12:59 pm

CORN

SOYB

SPY

VGK

Ukraine seeks to expand its grain deal with Russia to include new ports and more commodities in exchange for the inclusion of an ammonia pipeline in the agreement. The current Black Sea grain deal does not cover the transit of Russian ammonia through Ukraine.

Portfolio Pulse from Happy Mohamed

May 19, 2023 | 12:57 pm

SPY

VGK

The U.S. Commerce Department is revising recent restrictions targeting Iran's supply of drones to Russia. The blacklisted entities include 69 Russian entities, 1 Armenian entity, and 1 Kyrgyzstan entity.

Portfolio Pulse from Happy Mohamed

May 19, 2023 | 12:53 pm

ABT

STXS

Stereotaxis (NYSE:STXS) and Abbott (NYSE:ABT) announced a global collaboration to integrate Abbott's EnSite™ X EP System with Stereotaxis' Robotic Magnetic Navigation systems. The integrated technologies are cleared for use in Europe, with additional regulatory clearances expected in the coming months.

Portfolio Pulse from Happy Mohamed

May 19, 2023 | 12:40 pm

NBIX

Neurocrine Biosciences has announced the publication of full Kinect-HD Phase 3 study results of Valbenazine for the treatment of chorea associated with Huntington's disease in The Lancet Neurology.

Portfolio Pulse from Benzinga Newsdesk

May 19, 2023 | 12:33 pm

AZN

AstraZeneca's China president, Wang Lei, announced the company's intention to be a patriotic company in China that 'loves the Communist Party' during an event in Wuxi. This is less common for foreign companies. AstraZeneca has recently invested $450 million in a factory in China, which accounted for 13% of the company's overall sales in 2022.

Portfolio Pulse from Vandana Singh

May 19, 2023 | 12:25 pm

DISH

GOOG

GOOGL

MSFT

T

The FCC has allocated a portion of the 12 GHz band for satellite broadband services, including SpaceX's Starlink, despite opposition from other providers. The decision is significant as the 500 MHz of mid-band spectrum in the 12.2-12.7 GHz range is crucial for broadband communications.

Portfolio Pulse from Anan Ashraf

May 19, 2023 | 12:18 pm

ABBV

JNJ

TAK

The FDA has approved AbbVie's Rinvoq (upadacitinib) as the first oral treatment for moderately to severely active Crohn's disease patients. This marks the seventh FDA approval for Rinvoq across rheumatology, dermatology, and gastroenterology. Rinvoq competes with other biologics such as Johnson & Johnson's Stelara and Takeda Pharmaceutical's Entyvio.

Portfolio Pulse from Vandana Singh

May 19, 2023 | 12:13 pm